(Total Views: 536)
Posted On: 08/23/2020 2:55:25 PM
Post# of 145907
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
To the best of my knowledge, convalescent plasma is not at a marketable therapeutic, so it should not draw too much money from the companies of other therapeutics.
Gilead has EUA and is still down.
Leronlimab works.
Big media picking it up. I believe Forbes is a bit more important than proactive investors.
Cytodyn will continue to push incessantly forward.
Gilead has EUA and is still down.
Leronlimab works.
Big media picking it up. I believe Forbes is a bit more important than proactive investors.
Cytodyn will continue to push incessantly forward.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)